Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Hypertension, Intellectual disability, Major depression, Obsessive-compulsive disorder
Clinical narrative: PNEUMONIA; RIGHT FEMUR FRACTURE; UNSPECIFIED INTELLECTUAL DISORDER; MAJOR DEPRESSIVE DISORDER; PARKINSON'S DISEASE; SEIZURE DISORDER; ANXIETY; HYPERTENSION; CONSTIPATION; VITAMIN D DEFICIENCY; OBSESSIVE-COMPULSIVE DISORDER; IMPAIRED WALKING/MOBILITY; DRY EYE SYNDROME; URINARY INCONTINENCE; BENIGN PROSTATIC HYPERPLASIA; OSTEOARTHRITIS; PSYCHOTIC DISORDER; This spontaneous report received from a health care professional concerned a 69 year old male of an unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number and expiry were not reported) dose was not reported, 1 total, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 22-DEC-2021, the patient was admitted (hospitalized) to facility for nursing care due to pneumonia, right femur fracture, anxiety, hypertension (HTN), constipation, vitamin D deficiency, unspecified intellectual disorder, major depressive disorder, obsessive-compulsive disorder (OCD), Parkinson's Disease, impaired walking/mobility, seizure disorder, dry eye syndrome, urinary incontinence, benign prostatic hyperplasia (BPH), osteoarthritis, and psychotic disorder (dose number in series 1). Outbreak COVID-19 testing revealed negative tests throughout course of stay. Number of days of hospitalization was unknown. It was unknown if the patient was discharged. It was reported that, post form signed by representative and physician indicated comfort measures only. Resident was admitted with known historical administration of J and J COVID-19 vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pneumonia, right femur fracture, anxiety, hypertension, constipation, vitamin d deficiency, unspecified intellectual disorder, major depressive disorder, obsessive-compulsive disorder, Parkinson's disease, impaired walking/mobility, seizure disorder, dry eye syndrome, urinary incontinence, benign prostatic hyperplasia, osteoarthritis and psychotic disorder was not reported. This report was serious (Hospitalization Caused / Prolonged). This case, involving the same patient is linked to 20220124404 (dose number in series 2 case). This case, from the same reporter is linked to 20220124221.; Sender's Comments: V0:20220130332-COVID-19 VACCINE AD26.COV2.S-.Pneumonia, Right femur fracture, Anxiety, Hypertension, Constipation, Vitamin d deficiency, Unspecified intellectual disorder, Major depressive disorder, Obsessive-compulsive disorder, Parkinson's disease, Impaired walking/mobility, Seizure disorder, Dry eye syndrome, Urinary incontinence, Benign prostatic hyperplasia, Osteoarthritis ,Psychotic disorder - This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).